One of the biggest trends on the ASX in recent months has been the rise of ASX uranium shares. Uranium miners like Boss Energy Ltd (ASX: BOE) and Paladin Energy Ltd (ASX: PDN) have surged in value recently, thanks to a massive spike in the cost of uranium. But what about ASX uranium ETFs?
Like many commodities, the ASX hosts a few exchange-traded funds (ETFs) that are designed to give investors exposure to the uranium niche.
One such fund is the BetaShares Global Uranium ETF (ASX: URNM). URNM units have been a fantastic investment in recent times. Just today, this ETF hit a new all-time record high of $10.96 a unit. The fund is also up more than 100% since March 2023.
This ETF works by holding an underlying portfolio of companies that are all involved in the production, stockpiling and distribution of uranium fuel. URNM holds both Boss Energy and Paladin in its portfolio, but its largest holdings are the likes of Cameco Corp, Sprott Physical Uranium Trust and Nexgen Energy.
Another ASX uranium ETF is the Global X Uranium ETF (ASX: ATOM). This fund is almost identical to URNM, even down to sharing an annual management fee of 0.69%. It holds very similar companies within its portfolio and also offers exposure to all things uranium.
Are ASX uranium ETFs worth investing in today?
If you are looking for some exposure to uranium companies but with a diversified risk base, then one of these ASX uranium ETFs might be a good fit.
However, I would throw in a caveat. Remember, uranium stocks and by extension, these ETFs have already had a stunning 12 months or so. If uranium prices (which are already at multi-year highs) continue to surge, then we could well keep seeing some stonking gains here. But that's a big if. If uranium eventually returns to its historical levels, these ETFs could come off the boil quickly.
So in this way, you are effectively making a bet on the future of a volatile commodity price by investing in one of these funds. That's not the way I usually invest, and it's not something I would recommend to any investor without an in-depth understanding of the global uranium market.